Y 18598

used in therapy of leukemia P388; RN not in Chemline 7/85; structure given in first source

Also Known As:

4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17,-octadecanonaen-1,18-diyl)bis(1-ethylpyridium) dibromide; Y-18598; Pyridinium, 4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(1-ethyl)-, dibromide, (all-E)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Leukemia P388 01/01/1985 - "The life span of leukemic mice was increased by 56% over the control following administration of 2.5 mg/kg on days 1-5. Among these polyene-containing compounds, Y-18598 was the most highly cytotoxic to P388 leukemia cells in vitro."